Search Result "sunitinib"


Review Article

Sunitinib in the Treatment of Thyroid Cancer

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 6 Year: 2019 Page: 963-972
Author(s): Silvia Martina Ferrari,Marco Centanni,Camilla Virili,Mario Miccoli,Paola Ferrari,Ilaria Ruffilli,Francesca Ragusa,Alessandro Antonelli,Poupak Fallahi

High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 6 Year: 2012 Page: 693-702
Author(s): C. D'Alterio, L. Portella, A. Ottaiano, M. Rizzo, G. Carteni, S. Pignata, G. Facchini, S. Perdona, G. Di Lorenzo, R. Autorino, R. Franco, A. La Mura, O. Nappi, G. Castello, S. Scala

Sunitinib for the Treatment of Central Nervous System Glioma

Ebook: Young People’s Visions of the World
Volume: 1 Year: 2010
Author(s): Neyns Bart

Research Article

Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

Journal: Current Cancer Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 62-73
Author(s): Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal, Jose Luis Passos-Coelho

The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer: Our Experience and Review of Literature

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 9 Year: 2011 Page: 746-752
Author(s): G. Pasqualetti, S. Ricci, A. Dardano, M. Ferdeghini, M. Del Tacca, F. Monzani

Curcumin Potentiates The Ability of Sunitinib to Eliminate the VHL-lacking Renal Cancer Cells 786-O: Rapid Inhibition of Rb Phosphorylation as a Preamble to Cyclin D1 Inhibition

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 1508-1513
Author(s): Priya Ranjan Debata, Sultana Begum, Anita Mata, Oksana Genzer, Morton J. Kleiner, Probal Banerjee, Mario R. Castellanos

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 8 Year: 2011 Page: 944-953
Author(s): H. Huynh, S. P. Choo, H. C. Toh, W. M. Tai, A. Y.F. Chung, P. K.H. Chow, R. Ong, K. C. Soo

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 1649-1659
Author(s): Lale Erdem, Elisa Giovannetti, Leticia G Leon, Richard Honeywell, Godefridus J. Peters

Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6 Issue: 2 Year: 2012 Page: 171-176
Author(s): Giuseppe Pasqualetti, Sergio Ricci, Giuseppe Boni, Sara Tognini, Antonio Polini, Giuliano Mariani, Marco Ferdeghini, Fabio Monzani

Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 6 Year: 2009 Page: 738-747
Author(s): H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow, K. C. Soo

Previous   Next

Go To   Results 1 - 1 of 966

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy